3 issues to watch in pharma in 2024
As another year comes to an end and the world seems to hit the proverbial pause button, the temptation to look ahead is too great
As another year comes to an end and the world seems to hit the proverbial pause button, the temptation to look ahead is too great
Plus, news about Abilita Therapeutics, Orion, Novartis, XGEN Venture, Palleon, Henlius, TigaTx, HERVolution Therapeutics and Krystal Biotech: Gilead now owns 30% of Assembly Biosciences: The
What You Should Know: – CalmiGo, a pioneer in providing immediate relief and long-term care for anxiety, PTSD, and panic attacks, has unveiled its enhanced